One Novel Nortriterpenoid from the Mastic (<i>Pistacia lentiscus</i>) and Its Anti-Inflammatory Activity
Yue Wu,
No information about this author
Xuerui An,
No information about this author
Haofan Lv
No information about this author
et al.
Phyton,
Journal Year:
2025,
Volume and Issue:
0(0), P. 1 - 10
Published: Jan. 1, 2025
A
novel
pair
of
oleanane
nor-triterpenes,
with
compound
1
featuring
a
unique
18α-H
structure,
was
isolated
from
mastic,
and
this
represents
noteworthy
new
entity
not
previously
reported
in
the
literature.The
absolute
configurations
their
structures
were
further
determined
using
combination
different
analytical
methods
such
as
NMR,
high-resolution
mass
spectrometry
(HR-MS),
ultraviolet
(UV),
infrared
(IR)
single-crystal
X-ray
diffraction
(SXRD).The
actively
mitigated
inflammations
by
efficiently
quenching
nitric
oxide
(NO)
synthesis
within
an
ex
vivo
system
lipopolysaccharide
activated
murine
macrophage
RAW264.7
cells.Moreover,
exhibit
better
IC
50
concentration
11.69
±
1.39
µM,
surpassing
efficacy
positive
control
dexamethasone,
which
exhibited
23.21
1.17
μM.While
2
also
demonstrated
inhibitory
activity,
its
potency
comparatively
weaker,
26.18
2.66
μM.
Language: Английский
Salicylic acid-induced upregulation of AtAACT and AtMVD expression enhances triterpene biosynthesis in Athelia termitophila
Fangcheng Hu,
No information about this author
Y. Fang,
No information about this author
Lianxi Xing
No information about this author
et al.
World Journal of Microbiology and Biotechnology,
Journal Year:
2025,
Volume and Issue:
41(3)
Published: Feb. 27, 2025
Language: Английский
Biosynthesis of triterpenoids in plants: Pathways, regulation, and biological functions
Current Opinion in Plant Biology,
Journal Year:
2025,
Volume and Issue:
85, P. 102701 - 102701
Published: March 20, 2025
Language: Английский
A Direct Relationship Between ‘Blood Stasis’ and Fibrinaloid Microclots in Chronic, Inflammatory, and Vascular Diseases, and Some Traditional Natural Products Approaches to Treatment
Pharmaceuticals,
Journal Year:
2025,
Volume and Issue:
18(5), P. 712 - 712
Published: May 12, 2025
'Blood
stasis'
(syndrome)
(BSS)
is
a
fundamental
concept
in
Traditional
Chinese
Medicine
(TCM),
where
it
known
as
Xue
Yu
().
Similar
concepts
exist
Korean
('Eohyul')
and
Japanese
Kampo
medicine
(Oketsu).
Blood
stasis
considered
to
underpin
large
variety
of
inflammatory
diseases,
though
an
exact
equivalent
Western
systems
yet
be
described.
Some
time
ago
we
discovered
that
blood
can
clot
into
anomalous
amyloid
form,
creating
what
have
referred
fibrinaloid
microclots.
These
microclots
occur
great
many
chronic,
diseases
are
comparatively
resistant
fibrinolysis,
thus
the
ability
block
microcapillaries
hence
lower
oxygen
transfer
tissues,
with
multiple
pathological
consequences.
We
here
develop
idea
precisely
relate
to,
largely
mechanistically
responsible
for,
traditional
(a
term
also
used
by
Virchow).
First,
associated
all
stasis.
Secondly,
blocking
red
cell
transport,
provide
simple
mechanistic
explanation
for
physical
slowing
down
('stasis')
flow.
Thirdly,
herbal
formulae
proposed
treat
these
especially
Fu
Zhu
its
derivatives,
anticoagulatory
anti-inflammatory,
consistent
they
actually
helping
levels
microclots,
plausibly
part
catalysis
polymerization
fibrinogen
form.
rehearse
some
actions
constituent
herbs
specific
bioactive
molecules
contain.
Consequently,
such
formulations
(and
their
components),
which
little
science
medicine,
would
seem
offer
opportunity
novel,
safe,
useful
treatments
chronic
display
including
Myalgic
Encephalopathy/Chronic
Fatigue
Syndrome,
long
COVID,
even
ischemic
stroke.
Language: Английский
Malbrumpenoids A-N, unusually cyclized triterpenoids from the Euphorbia endophyte Malbranchea umbrina D16
Chinese Chemical Letters,
Journal Year:
2025,
Volume and Issue:
unknown, P. 111336 - 111336
Published: May 1, 2025
Language: Английский
Yinling Qushi Granule as a therapeutic agent for metabolic syndrome: pharmacological, molecular targets, and pharmacokinetic insights
Linlin Jin,
No information about this author
Shaoqin Lin,
No information about this author
He Yan
No information about this author
et al.
Advanced Biotechnology,
Journal Year:
2025,
Volume and Issue:
3(2)
Published: May 30, 2025
Abstract
Metabolic
Syndrome
(MetS)
is
a
globally
prevalent
condition
with
unclear
underlying
mechanisms.
Current
treatments
primarily
focus
on
alleviating
individual
symptoms,
lacking
long-term
therapeutic
strategies
that
target
the
disease’s
endotypes.
In
this
study,
we
found
Yinling
Qushi
Granule
(YLQSG),
formulated
prescription
for
treating
Dampness
(DS)
in
Traditional
Chinese
Medicine
(TCM),
effectively
attenuated
hypertension
associated
MetS.
After
12
weeks
of
YLQSG
treatment,
MetS
patients
showed
significant
reduction
systolic
and
diastolic
blood
pressure,
body
mass
index
(BMI)
glycated
hemoglobin
(HbA1c).
Chemical
analysis
has
identified
total
96
components
YLQSG,
alongside
27
serum
absorbed
prototypes
13
metabolites.
vivo
metabolic
profiling
revealed
critical
Phase
I
metabolism
including
dehydration,
demethylation,
oxidation.
By
integrating
network
pharmacology
molecular
docking,
proposed
11
triterpenoids
from
sovereign
herb
Poria
cocos
(Schw.)
Wolf
as
active
constituents
YLQSG.
These
potent
binding
affinities
AGTR1
11β-HSD1,
two
crucial
druggable
targets
renin–angiotensin–aldosterone
system.
Pharmacokinetics
these
lanosterol-type
rat
indicated
their
good
drug
likeness
properties.
summary,
our
findings
highlight
potential
MetS,
particularly
hypertension,
identify
its
compounds
targets,
offering
promising
alternative
strategy
management
Trial
registration
ChiCTR,
ChiCTR2200063506.
Registered
9
September
2022,
https://www.chictr.org.cn/showproj.html?proj=174653
.
Language: Английский